Cargando…

COVID-19-Associated Pulmonary Aspergillosis in a Patient Treated With Remdesivir, Dexamethasone, and Baricitinib: A Case Report

Remdesivir, dexamethasone, and baricitinib have recently been used to treat patients with coronavirus disease 2019 (COVID-19) and respiratory failure. However, the adverse effects of combination therapy have not been fully explored. A 64-year-old man was diagnosed with COVID-19 and was treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimada, Ayako, Ohnaka, Shinnosuke, Kubo, Kosumi, Nakashima, Masanao, Nagai, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Radiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064704/ https://www.ncbi.nlm.nih.gov/pubmed/35518522 http://dx.doi.org/10.7759/cureus.23755

Ejemplares similares

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022)

Concomitant Pulmonary Aspergillosis Following Severe COVID-19
por: Munir, Ahmad, et al.
Publicado: (2023)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
por: Yasuda, Yuto, et al.
Publicado: (2022)

Systemic Aspergillosis: Radiological Findings in a Case With Diffuse Large B Cell Lymphoma Treated by Ibrutinib
por: Pehlivan, Umur Anil, et al.
Publicado: (2021)

507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study
por: Dea, Lauren, et al.
Publicado: (2021)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Dexamethasone: Bordetella hinzii pneumonia and pulmonary aspergillosis: case report
Publicado: (2022)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

Pictorial essay: Allergic bronchopulmonary aspergillosis
por: Agarwal, Ritesh, et al.
Publicado: (2011)

Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Acute pancreatitis: case report
Publicado: (2022)

Dexamethasone/salmeterol/fluticasone-propionate: Invasive pulmonary Aspergillosis: case report
Publicado: (2021)

Dexamethasone/propofol/remdesivir: Various toxicities: case report
Publicado: (2021)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone: Chronic cavitary pulmonary aspergillosis and off label use: case report
Publicado: (2022)

Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021)

Metastatic Prostatic Adenocarcinoma Masquerading as Pulmonary Tuberculosis: A Case Report
por: Vohra, Mona, et al.
Publicado: (2022)

Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan
por: Hirasawa, Yasutaka, et al.
Publicado: (2023)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

Traumatic Splenic Infarction and Pulmonary Embolism: A Case Report of Rare Radiological Finding
por: Sinha, Mithilesh K, et al.
Publicado: (2021)

Pneumocystis Pneumonia With Multiple Centrilobular Pulmonary Nodules and Lack of Ground-Glass Attenuation on High-Resolution Computed Tomography
por: Takaki, Ryuichiro, et al.
Publicado: (2023)

Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study
por: So, Jessica M, et al.
Publicado: (2021)

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
por: Pérez-Alba, Eduardo, et al.
Publicado: (2021)

Pulmonary Actinomycosis Mimicking Pulmonary Cancer on Fluorine-18 Fluorodeoxyglucose PET-CT
por: Tanaka, Shota, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19)-Associated Thromboembolic Disease: A Report of Three Patients With Pulmonary Embolism
por: Guccione, Jeffrey, et al.
Publicado: (2020)

Grade III Spleen Laceration After a Colonoscopy Treated with Splenic Artery Embolization: A Case Report
por: Ahmed, Mohamed, et al.
Publicado: (2019)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uh9jt1g9h0ele2t8f0m9skgltm